RS
ALT icon

R Squared’s Altimmune ALT Stock Holding History

R Squared’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3K Buy
+13,264
New +$39.6K 0.02% 460
2025
Q1 		– Sell
-2,930
Closed -$21.1K – 339
2024
Q4 		$21.1K Buy
+2,930
New +$22.4K 0.02% 851

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

R Squared's ALT Position: Q2 2026 in Review

R Squared opened a new position in Altimmune (ALT) in Q2 2026: 13,264 shares worth $40.3K. The stake represents 0.02% of the portfolio and ranks #460 among its holdings. This is a return to the name: R Squared previously reported a position in ALT as recently as Q4 2024.

R Squared first reported a position in ALT in Q4 2024 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • R Squared held 13,264 shares of Altimmune worth $40.3K as of Q2 2026.
  • Altimmune was a new R Squared position in Q2 2026.
  • Altimmune made up 0.02% of R Squared's portfolio in Q2 2026, its #460 holding.
  • R Squared first reported a position in Altimmune in Q4 2024 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.